[SCHEDULE 13G/A] Utah Medical Products Inc SEC Filing

Rhea-AI Filing Summary

Brandes Investment Partners, L.P. filed an amendment to Schedule 13G reporting beneficial ownership of 333,204 common shares of Utah Medical Products Inc (UTMD), representing 10.39% of the class. The filing shows Brandes has shared voting power over 286,784 shares and shared dispositive power over 333,204 shares, with no sole voting or dispositive power. The form states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing identifies the reporting person as an investment adviser organized in Delaware and lists principal office at 4275 Executive Square, La Jolla, CA. The signature on the amendment is dated 09/02/2025.

Insights

Securities Analyst

TL;DR: Brandes reports a >10% passive stake in UTMD, disclosed under Schedule 13G rules.

The filing shows a material passive ownership position of 333,204 shares (10.39%), which meets regulatory thresholds requiring public disclosure. Classification as a Schedule 13G filing and the certification language indicate Brandes asserts the stake is held in the ordinary course of business and not to influence control. Voting and dispositive powers are reported as shared, which is typical for investment advisors acting on behalf of clients. This is a routine, non-activist ownership disclosure that informs investors and the market of a significant investor position without signaling active control efforts.

Compliance/Risk Analyst

TL;DR: Disclosure appears complete for a Schedule 13G amendment and aligns with passive investor reporting requirements.

The amendment contains required identification, ownership percentages, voting/dispositive power breakdowns, and the certification asserting ordinary-course purposes. The reported 10.39% ownership surpasses the 5% reporting threshold, triggering the amendment. Signature and address details are provided. There is no indication in the filing of coordinated group activity or intent to change control, reducing immediate regulatory or governance concerns based on this document alone.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

UTAH MEDICAL PRODUCTS INC

(Name of Issuer)

Common Shares

(Title of Class of Securities)

917488108

(CUSIP Number)

08/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 917488108

1

Names of Reporting Persons

BRANDES INVESTMENT PARTNERS, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 286,784.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 333,204.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

333,204.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.4 %

12

Type of Reporting Person (See Instructions)

IA, PN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: UTAH MEDICAL PRODUCTS INC
(b)	Address of issuer's principal executive offices: 7043 S 300 WEST, MIDVALE, UTAH, 84070.
Item 2.
(a)	Name of person filing: Brandes Investment Partners, L.P.
(b)	Address or principal business office or, if none, residence: 4275 Executive Square, 5th Floor, La Jolla, CA 92037
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: 917488108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 333,204
(b)	Percent of class: 10.39 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 286,784
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 333,204
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BRANDES INVESTMENT PARTNERS, LP

Signature:	/s/ Glenn Carlson
Name/Title:	Executive Director
Date:	09/02/2025